Background: Although surgical intervention is the therapeutic mainstay for epiphora secondary to nasolacrimal obstruction, offlabel injection of onabotulinumtoxinA (BTX-A) into the lacrimal gland has emerged as an effective, minimally invasive alternative. We investigated the structural and molecular changes within the lacrimal gland of the New Zealand White rabbit model, following intraglandul...
